French diabetes and obesity specialist Adocia was trading 45% higher late Friday following its partner Tonghua Dongbao’s ...

In a small cell therapy trial, 10 out of 12 people with type 1 diabetes no longer needed supplemental insulin, even a year after treatment.

If you have insulin resistance—or are worried about developing it—you might be considering supplements that claim to help manage this condition. But are they really effective?

Retinopathy: the studies carried out concluded that insulin lispro therapy has no adverse impact on progression of retinopathy in pregnant women with Type 1 or Type 2 diabetes ( Table 4 ).

A Canadian woman with type 1 diabetes spent nearly a decade dependent on her glucose monitor and insulin shots — but after a single dose of manufactured stem cells implanted into her liver, she ...

BOSTON (WHDH) - Researchers at Vertex Pharmaceuticals in Boston say a single infusion of stem cell-based treatment could be a permanent solution for insulin. They say it has been tested on 12 ...

Long-lasting insulin takes another step forward with latest clinical trial results Scripps researcher delivers findings for Lilly drug expected to request approval from FDA soon ...

While many systems already pair continuous glucose monitors (CGMs) and insulin pumps, PharmaSens and SiBionics may have something different.

Next-gen Medtronic insulin pump reportedly set for FDA submission, patch pump on the way June 23, 2025 By Sean Whooley ...

Lilly's once-weekly insulin efsitora alfa demonstrated A1C reduction and a safety profile consistent with daily insulin in multiple Phase 3 trials ...

It's an allogeneic stem cell-derived, fully differentiated insulin-producing islet cell therapy that is delivered by infusion into the portal vein over a period of 30-60 minutes.